基本信息
浏览量:51
职业迁徙
个人简介
Our team works in a multidisciplinary approach using Nanotechnology to combat devastating diseases like Breast and lung cancer. One of the emphases here is to overcome lung cancer mutations which are induced after using various Tyrosine kinase inhibitors. Our laboratory is using various novel compounds which are acting as chemosensitizers and help in overcoming resistance in lung and breast cancers. We are also using exosomes as markers of tumor progression which can enable in diagnosis and tumor progression as a liquid biopsy. Another emphasis is to use 3D printing approaches to develop tumor scaffolds and also to conduct cytotoxicity assays using 3D printed co-cultures of tumor cells and fibroblasts. Apart from this our team is also printing Cornea using various bioinks.
研究兴趣
论文共 305 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Pharmaceuticsno. 1 (2024): 83
Scientific Reportsno. 1 (2024): 1-9
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMSno. 1 (2024): 1-33
Cancer Letters (2023): 216243-216243
引用0浏览0WOS引用
0
0
International journal of molecular sciencesno. 8 (2023): 7660-7660
Pharmaceuticsno. 2200 (2023): 2200-2200
引用0浏览0WOS引用
0
0
AAPS PharmSciTechno. 4 (2023): 88-12
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn